1
|
Bouza E, Vargas F, Alcázar B, Álvarez T, Asensio A, Cruceta G, Gracia D, Guinea J, Gil MA, Linares C, Muñoz P, Pastor P, Pedro-Botet ML, Querol X, Tovar J, Urrutia I, Villar F, Palomo E. Air pollution and health prevention: A document of reflection. Rev Esp Quimioter 2022; 35:307-332. [PMID: 35277084 PMCID: PMC9333116 DOI: 10.37201/req/171.2021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Ambient air quality, pollution and its implication on health is a topic of enormous importance that is normally dealt with by major specialists in their particular areas of interest. In general, it is not discussed from multidisciplinary approaches or with a language that can reach everyone. For this reason, the Health Sciences Foundation, from its prevention area, has formulated a series of questions to people with very varied competences in the area of ambient air quality in order to obtain a global panorama of the problem and its elements of measurement and control. The answers have been produced by specialists in each subject and have been subjected to a general discussion that has allowed conclusions to be reached on each point. The subject was divided into three main blocks: external ambient air, internal ambient air, mainly in the work-place, and hospital ambient air and the consequences of its poor control. Along with the definitions of each area and the indicators of good and bad quality, some necessary solutions have been pointed out. We have tried to know the current legislation on this problem and the competences of the different administrations on it. Despite its enormous importance, ambient air quality and health is not usually a topic of frequent presence in the general media and we have asked about the causes of this. Finally, the paper addresses a series of reflections from the perspective of ethics and very particularly in the light of the events that the present pandemic raises. This work aims to provide objective data and opinions that will enable non-specialists in the field to gain a better understanding of this worrying reality.
Collapse
Affiliation(s)
- E Bouza
- Servicio de Microbiología Clínica y Enfermedades Infecciosas del Hospital General Universitario Gregorio Marañón, Universidad Complutense. CIBERES. Ciber de Enfermedades Respiratorias. Madrid, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
2
|
Gheyath B, Akram A, Gong R, Tovar J, Amsterdam E, Venugopal S. A 70-Year-Old Man With Conspicuous Thigh Pain and ST-Segment Elevations. Chest 2021; 159:e403-e407. [PMID: 34099158 DOI: 10.1016/j.chest.2021.01.033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2020] [Revised: 12/08/2020] [Accepted: 01/09/2021] [Indexed: 10/21/2022] Open
Abstract
CASE PRESENTATION A 70-year-old man presented to the ED with sudden onset of left thigh pain followed by transient chest discomfort. His history included cerebrovascular disease, hypertension, and cocaine and methamphetamine use. Physical examination revealed an uncomfortable male subject with a temperature of 37 °C, heart rate of 129 beats/min, BP of 130/65 mm Hg, and 98% oxygen saturation on room air. There was point tenderness in the left lateral thigh without erythema, swelling, or overlying skin changes. His cardiac examination revealed an irregular tachycardia at 129 beats/min and normal first and second heart sounds without murmurs, gallops, or rubs. The remainder of the examination was unremarkable.
Collapse
Affiliation(s)
- Bashaer Gheyath
- Division of Cardiovascular Medicine, University of California Davis Health System, Sacramento, CA.
| | - Alirameen Akram
- California Northstate University College of Medicine, Elk Grove, CA
| | - Raymond Gong
- Department of Pathology and Laboratory Medicine, University of California Davis Health System, Sacramento, CA
| | - Jason Tovar
- Department of Pathology and Laboratory Medicine, University of California Davis Health System, Sacramento, CA
| | - Ezra Amsterdam
- Division of Cardiovascular Medicine, University of California Davis Health System, Sacramento, CA
| | - Sandhya Venugopal
- Division of Cardiovascular Medicine, University of California Davis Health System, Sacramento, CA
| |
Collapse
|
3
|
Bouza E, Martín Jiménez M, Alemany L, Arribas J, Bañares R, Barragán MB, Eiros Bouza JM, Felip E, Fernández-Capetillo O, Gracia D, López-Vélez R, Bautista Mollar J, Muñoz P, Paz-Ares L, Torné A, Tovar J, Valencia E, Palomo E. Overview of virus and cancer relationships. Position paper. Rev Esp Quimioter 2020; 34:525-555. [PMID: 34348449 PMCID: PMC8638760 DOI: 10.37201/req/058.2021] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
The role of certain viruses in the etiology of some tumors is today indisputable, but there is a lack, however, of annoverview of the relationship between viruses and cancer with amultidisciplinary approach. For this reason, the Health Sciences Foundation has convened a group of professionals from different areas of knowledge to discuss the relationship between viruses and cancer, and the present document is the result of these deliberations. Although viruses cause only 10-15% of cancers, advances in oncology research are largely due to the work done during the last century on tumor viruses. The clearest cancer-inducing viruses are: HPV, HBV, HCV, EBV and, depending on the geographical area, HHV-8, HTLV-1 and HIV. HPVs, for example, are considered to be the causative agents of cervical carcinomas and, more recently, of a proportion of other cancers. Among the Herpes viruses, the association with the development of neoplasms is well established for EBV and HHV-8. Viruses can also be therapeutic agents in certain neoplasms and, thus, some oncolytic viruses with selective tropism for tumor cells have been approved for clinical use in humans. It is estimated that the prophylaxis or treatment of viral infections could prevent at least 1.5 million cancer deaths per year.
Collapse
Affiliation(s)
- E Bouza
- Emilio Bouza, Instituto de Investigación Sanitaria Gregorio Marañón. C/ Dr. Esquerdo, 46 28007 Madrid, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - E Palomo
- Esteban Palomo, Director. Health Sciences Foundation. C/ Severo Ochoa 2 - 28760 Tres Cantos. Madrid. Phone +34 91 3530150
| |
Collapse
|
4
|
Gin K, Tovar J, Bartelink EJ, Kendell A, Milligan C, Willey P, Wood J, Tan E, Turingan RS, Selden RF. The 2018 California Wildfires: Integration of Rapid DNA to Dramatically Accelerate Victim Identification. J Forensic Sci 2020; 65:791-799. [PMID: 32128817 PMCID: PMC7318200 DOI: 10.1111/1556-4029.14284] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2019] [Revised: 12/28/2019] [Accepted: 01/03/2020] [Indexed: 12/02/2022]
Abstract
In November 2018, Butte County, California, was decimated by the Camp Fire, the deadliest wildfire in state history. Over 150,000 acres were destroyed, and at its peak, the fire consumed eighty acres per minute. The speed and intensity of the oncoming flames killed scores of people, and weeks before the fire was contained, first responders began searching through the rubble of 18,804 residences and commercial buildings. As with most mass disasters, conventional identification modalities (e.g., fingerprints, odontology, hardware) were utilized to identify victims. The intensity and duration of the fire severely degraded most of the remains, and these approaches were useful in only 22 of 84 cases. In the past, the remaining cases would have been subjected to conventional DNA analysis, which may have required months to years. Instead, Rapid DNA technology was utilized (in a rented recreational vehicle outside the Sacramento morgue) in the victim identification effort. Sixty‐nine sets of remains were subjected to Rapid DNA Identification and, of these, 62 (89.9%) generated short tandem repeat profiles that were subjected to familial searching; essentially all these profiles were produced within hours of sample receipt. Samples successfully utilized for DNA identification included blood, bone, liver, muscle, soft tissue of unknown origin, and brain. In tandem with processing of 255 family reference samples, 58 victims were identified. This work represents the first use of Rapid DNA Identification in a mass casualty event, and the results support the use of Rapid DNA as an integrated tool with conventional disaster victim identification modalities.
Collapse
Affiliation(s)
- Kim Gin
- Sacramento County Coroner's Office, 4800 Broadway, Sacramento, CA, 95820
| | - Jason Tovar
- Sacramento County Coroner's Office, 4800 Broadway, Sacramento, CA, 95820
| | - Eric J Bartelink
- Department of Anthropology, California State University, 400 West First Street, Chico, CA, 95929
| | - Ashley Kendell
- Department of Anthropology, California State University, 400 West First Street, Chico, CA, 95929
| | - Colleen Milligan
- Department of Anthropology, California State University, 400 West First Street, Chico, CA, 95929
| | - P Willey
- Department of Anthropology, California State University, 400 West First Street, Chico, CA, 95929
| | - James Wood
- Sonoma County Sheriff-Coroner Office, 3336 Chanate Road, Santa Rosa, CA, 95404
| | - Eugene Tan
- ANDE Corporation, 266 Second Avenue, Waltham, MA, 024551
| | | | | |
Collapse
|
5
|
Gao G, Tovar J, Raven K. An Autopsy Case of Severe Nonimmune Hydrops Fetalis Secondary to Premature Closure of the Foramen Ovale. Am J Clin Pathol 2019. [DOI: 10.1093/ajcp/aqz114.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Hydrops fetalis is a condition in the fetus characterized by excessive fluid accumulation within the fetal extravascular compartments and body cavities occurring prenatally. Nonimmune hydrops fetalis is the predominant (>85%) cause of all affected individuals (cardiovascular is the leading etiological category). Herein we present an autopsy case of severe nonimmune hydrops fetalis. The decedent was delivered from a blood type A Rh-positive mother. The overall autopsy findings are diffuse subcutaneous edema, significant ascites, pleural effusion, and pericardial effusion. The major autopsy finding is the premature closure of the foramen ovale of the heart, in addition to enlarged heart and liver. Premature closure of the foramen ovale may occur at any stage of pregnancy and may be due to multiple causes and has been reported as a cause of hydrops fetalis. It is well known that the foramen ovale is the shortcut through which the fetal heart provides oxygenated blood to preferential organs, mainly the brain and the heart itself, and normally closes at birth. The timing of the premature closure of the foramen ovale in fetus is critical: its closure late during pregnancy has been associated with right heart failure, while its closure very early during pregnancy frequently results in a hypoplastic left heart due to decreased blood flow, with an aneurysm consistently bulging into the left atrium, which ultimately leads to right heart failure. Both, if uncorrected in time, can ultimately lead to hydrops fetalis and fetal death. Other structural abnormalities, like pulmonary vascular disease/irreversible pulmonary hypertension, and enlarged edematous placenta, may further aggravate obstruction to venous return to fetal heart, setting up a vicious cycle. In summary, the newborn baby died of complications of nonimmune hydrops fetalis due to the premature closure of the foramen ovale of the heart.
Collapse
|
6
|
Aras-López R, Almeida L, Andreu-Fernández V, Tovar J, Martínez L. Anti-oxidants correct disturbance of redox enzymes in the hearts of rat fetuses with congenital diaphragmatic hernia. Pediatr Surg Int 2018; 34:307-313. [PMID: 29079903 DOI: 10.1007/s00383-017-4201-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 10/12/2017] [Indexed: 01/20/2023]
Abstract
AIM To evaluate if the redox system is unbalanced in the hearts of nitrofen-induced congenital diaphragmatic hernia (CDH) animals and to study the possible preventive effects of two anti-oxidant treatments, apocynin and epigallocatechin-3-gallate (EGCG). METHODS Adult rats were divided into four groups. Group 1: rats received only vehicle on day E9.5. Group 2: rats received 100 mg nitrofen on day E9.5. Group 3: 1 month before mating rats received apocynin 1.5 mM and, when pregnant, 100 mg nitrofen on day E9.5. Group 4: same than group 3 but with EGCG 30 mg/kg. All fetuses were recovered at term and the hearts were processed. Nox activity and mRNA levels of Nox1, Nox2, Nox4, SOD1, SOD2, SOD3, catalase, and GPX1 were analyzed. Nox, SOD, and Catalase activity and H2O2 production were also evaluated. RESULTS Nox activity, H2O2 production and Nox1, Nox2, and Nox4 mRNA levels were increased in the hearts of fetuses with CDH. There were no changes in SOD1 levels, whereas those of SOD2, SOD3, catalase, and GPX1 mRNA were decreased. Apocynin and EGCG treatments attenuated the increment of Nox and SOD activities and H2O2 production was only decreased by apocynin. CONCLUSION These findings suggest a possible preventive effect on the abnormal redox metabolism of anti-oxidant treatments in the hearts from rat fetuses with CDH. If the same occurs in humans, it could represent a potential tool in future prenatal treatment.
Collapse
Affiliation(s)
- Rosa Aras-López
- Congenital Malformations Lab, Institute of Medicine and Molecular Genetic (INGEMM), Institute for Health Research of La Paz Universitary Hospital (IdiPAZ), Madrid, Spain.
| | - L Almeida
- BCNatal, Barcelona Center for Maternal-Fetal Medicine and Neonatology, Hospital Clinic and Hospital San Joan de Deu, IdiBaps, University of Barcelona, Barcelona, Spain
| | - V Andreu-Fernández
- Fundació Clínic per la Recerca Biomèdica, BCNatal, GRIE, ICGON, Barcelona Center for Maternal-Fetal Medicine and Neonatology, Servicio de Neonatologia, Hospital Clinic-Maternitat, Barcelona, Spain
| | - J Tovar
- Department of Pediatric Surgery, Hospital Universitario La Paz, Madrid, Spain
| | - L Martínez
- Congenital Malformations Lab, Institute of Medicine and Molecular Genetic (INGEMM), Institute for Health Research of La Paz Universitary Hospital (IdiPAZ), Madrid, Spain.,Department of Pediatric Surgery, Hospital Universitario La Paz, Madrid, Spain
| |
Collapse
|
7
|
Murray JC, Rainusso N, Roberts RA, Gomez AM, Egler R, Russell H, Okcu MF, Gururangan S, Fangusaro J, Young-Poussaint T, Lesh S, Onar A, Gilbertson R, Packer R, McLendon R, Friedman HS, Boyett J, Kun LE, Venkatramani R, Haley K, Gilles F, Sposto R, Ji L, Olshefski R, Garvin J, Tekautz T, Kennedy G, Rassekh R, Moore T, Gardner S, Allen J, Shore R, Moertel C, Atlas M, Lasky J, Finlay J, Valera ET, Brassesco MS, Scrideli CA, Oliveira RS, Machado HR, Tone LG, Finlay JL, Kreimer S, Dagri J, Grimm J, Bluml S, Britt B, Dhall G, Gilles F, Finlay JL, Brown RJ, Dhall G, Shah A, Kapoor N, Abdel-Azim H, Rao AAN, Wallace D, Boyett J, Gajjar A, Packer RJ, Pearlman ML, Sadighi Z, Bingham R, Vats T, Khatua S, Ko RH, O'Neil S, Lavey RS, Finlay JL, Dhall G, Davidson TB, Gilles F, Tovar J, Grimm J, Wong K, Olch A, Dhall G, Finlay JL, Murray JC, Honeycutt JH, Donahue DJ, Head HW, Alles AJ, Ray A, Pearlman M, Vats T, Khatua S, Baskin J, Qaddoumi I, Ahchu MS, Alabi SF, Arambu IC, Castellanos M, Gamboa Y, Martinez R, Montero M, Ocampo E, Howard SC, Finlay JL, Broniscer A, Baker SD, Baker JN, Panandiker AP, Onar-Thomas A, Chin TK, Merchant TE, Davidoff A, Kaste SC, Gajjar A, Stewart CF, Espinoza J, Haley K, Patel N, Dhall G, Gardner S, Jeffrey A, Torkildson J, Cornelius A, Rassekh R, Bedros A, Etzl M, Garvin J, Pradhan K, Corbett R, Sullivan M, McGowage G, Puccetti D, Stein D, Jasty R, Ji L, Sposto R, Finlay JL, Antony R, Gardner S, Patel M, Wong KE, Britt B, Dhall G, Grimm J, Krieger M, McComb G, Gilles F, Sposto R, Finlay JL, Davidson TB, Sanchez-Lara PA, Randolph LM, Krieger MD, Wu S, Panigrahy A, Shimada H, Erdreich-Epstein A, Puccetti DM, Patel N, Kennedy T, Salamat S, Bradfield Y, Park HJ, Yoon JH, Ahn HS, Shin HY, Kim SK, Im HJ, Ra YS, Won SC, Baek HJ, Sung KW, Hah JO, Lim YT, Lee GS, Lee YH, Kim HS, Park JK, Kim MK, Park JE, Chung NG, Choi HS, Campen CJ, Fisher PG, Ruge MI, Simon T, Suchorska B, Lehrke R, Hamisch C, Koerber F, Treuer H, Berthold F, Sturm V, Voges J, Davidson TB, Finlay JL, Dhall G, Kirsch M, Lindner C, Schackert G, Brown RJ, Krieger M, Dhall G, Finlay JL. PEDIATRICS CLINICAL RESEARCH. Neuro Oncol 2011. [DOI: 10.1093/neuonc/nor156] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
8
|
Silva-Cristobal L, Osorio-Díaz P, Tovar J, Bello-Pérez LA. Chemical composition, carbohydrate digestibility, and antioxidant capacity of cooked black bean, chickpea, and lentil Mexican varieties Composición química, digestibilidad de carbohidratos, y capacidad antioxidante de variedades mexicanas cocidas de frijol negro, garbanzo, y lenteja. CyTA - Journal of Food 2010. [DOI: 10.1080/19476330903119218] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
|
9
|
Pascual-Castroviejo I, Pascual-Pascual SI, Velazquez-Fragua R, García-Guereta L, López-Gutiérrez JC, Olivares P, Tovar J. Association of cutaneous red-to-purple hemangiomas with leptomeningeal hemangiomas. a clinical study of two patients. Neuropediatrics 2010; 41:7-11. [PMID: 20571984 DOI: 10.1055/s-0030-1254102] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
Cutaneous hemangioma is a benign vascular tumor of infancy with an initial proliferating period that appears between 1 to 2 weeks of life, extends during 18 months to 2 years of life, and then slowly regresses during several years until it disappears completely. They are characterized by endothelial cell proliferation followed by diminishing hyperplasia and progressive fibrosis. Vascular malformations are present at birth, grow commensurately with the child, and are characterized histologically by a normal rate of endothelial cell turnover, flat endothelium, thin (normal) basal membrane and normal mast cells. These cutaneous anomalies are commonly associated with cerebellar malformations, main cerebral arteries anomalies, congenital cardiac anomalies and/or coarctation of the aorta and persistence of embryonic arteries. Cutaneous hemangiomas can be associated with intracranial or extracranial hemangiomas that regress at the same time as the cutaneous hemangiomas. Cutaneous hemangiomas may show different types of color. Cutaneous red-to-purple hemangiomas are uncommon and their bright-red color is evident from the first weeks of life and remains unaltered until the hemangioma disappears. The intracranial angiographic studies in our series of more than 50 cases with facial hemangioma showed that patients with red-to-purple hemangiomas are commonly associated with localized leptomeningeal hemangiomas either in the ipsilateral or contralateral side. These leptomingeal hemangiomas were visualized only by MR enhanced with gadolinium. Involution of the cutaneous and leptomeningeal hemangiomas seems to occur simultaneously as in other types of external and internal hemangiomas.
Collapse
|
10
|
Rendón-Villalobos J, Bello-Pérez L, Agama-Acevedo E, Islas-Hernández J, Osorio-Díaz P, Tovar J. Composition and characteristics of oil extracted from flaxseed-added corn tortilla. Food Chem 2009. [DOI: 10.1016/j.foodchem.2009.03.080] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
11
|
Osorio-Díaz P, Agama-Acevedo E, Mendoza-Vinalay M, Tovar J, Bello-Pérez LA. PASTA ADDED WITH CHICKPEA FLOUR: CHEMICAL COMPOSITION,IN VITROSTARCH DIGESTIBILITY AND PREDICTED GLYCEMIC INDEX PASTA ADICIONADA CON HARINA DE GARBANZO: COMPOSICIÓN QUÍMICA, DIGESTIBILIDADIN VITRODEL ALMIDÓNY PREDICCIÓN DEL ÍNDICE GLUCÉMICO. ACTA ACUST UNITED AC 2008. [DOI: 10.1080/11358120809487621] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
|
12
|
Aguilar R, Soto C, Barrena S, Díaz M, López JC, Ros Z, Tovar J. [A satisfaction survey of the evolution of 238 otoplasty]. Cir Pediatr 2008; 21:104-106. [PMID: 18624280] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
PURPOSE The prominent ear is a frequent problem that can be a source of important psychosocial troubles. The aim of this paper has been to evaluate the psychosocial repercussion, cosmetic result and degree of satisfaction in patients treated at our Institution for prominent ears in the last 4 years. MATERIAL AND METHODS A questionnaire has been sent to 127 patients. All of them underwent Mustarde's otoplasty. RESULTS 238 otoplasty were performed in 127 patients (87% bilateral procedures). The mean age was 8.15 +/- 3.25 years (range: 1-15 years), with a follow-up of 27.15 +/- 13.62 months (range: 4-52 months). Sixty-two % of the patients underwent otoplasty without having self-image affected while 38% of the group were patients older enough to see surgery to correct a long-standing defect. Patients did not require a period of postoperative psychosocial adjustment to their new appearance. Two patients described their results of surgery as little improvement. Three undergo partial recurrence and 5 suffered from total recurrence. All of the patients resume their lives with an improved level of self confidence. Conclusions. Otoplasty is a safe procedure for prominent ears to be considered in children with psycosocial, emotional or behavioural effects.
Collapse
Affiliation(s)
- R Aguilar
- Departamento de Cirugía Pediátrica, Hospital Infantil La Paz, Madrid.
| | | | | | | | | | | | | |
Collapse
|
13
|
Rodríguez-Ambriz S, Islas-Hernández J, Agama-Acevedo E, Tovar J, Bello-Pérez L. Characterization of a fibre-rich powder prepared by liquefaction of unripe banana flour. Food Chem 2008. [DOI: 10.1016/j.foodchem.2007.10.007] [Citation(s) in RCA: 109] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
14
|
Aguilar R, Andrés A, Barrena S, Burgos L, Suárez O, Lassaletta L, Tovar J. [Reoperations in gastroesophageal reflux disease]. Cir Pediatr 2008; 21:92-95. [PMID: 18624277] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
PURPOSE The purpose was to determinate the indications in which the failure of the surgical treatment of the gastroesophageal reflux disease (GERD) is more frequent and to analyze the results of the reinterventions. PATIENTS AND METHOD We made a restrospective review of the patients who underwent reoperation at our Institution during 1992-2006. RESULTS 19 of 252 Nissen underwent reoperation. In one case was the fourth fundoplication, in another was the third and the second in the rest of them. The reflux was confirmed by upper gastrointestinal contrast study, endoscopy, pH monitoring and, in some cases, manometry. 5 cases have surgical comorbidity (3 Esophageal Atresia (EA), 2 Congenital diaphragmatic hernia (CDH), 4 patients was neurologically impaired, 1 had caustic stenosis (CS), and 9 only symptoms of GERD. 8.7% of the patients with GERD, 5.8% of the neurologically impaired children, 10% of the EA, 20% of the CDH and 50% of the CS underwent redo Nissen. The mean time between first and second fundoplication was 1.6 years (range = 1 m-5.5 y). It was 11.2 in neurologically impaired patients, 5 m in CS, 11.5 m in CDH, 2.4 y in EA and 2.8 y in the rest. In patients with respiratory disease, the mean was 1.1 y and 1.9 y in the rest. The mechanism of failure was herniation of the fundoplication through the hiatus in 8 cases, wrap incompetence in 4 and wrap dehiscence in 2. In 5 patients it couldn't be determined. There were 2 postoperative complications. The mean follow-up was 5.3 years (range = 6-151.5 m). There was no cases of mortality. 17 of the 19 patients (89.4%) are free of symptoms and don't need more treatments. The child with CS continuous periodic esophageal dilatations and 1 of the patients with EA has dysphagia to solid foods.
Collapse
Affiliation(s)
- R Aguilar
- Departamento de Cirugía Pediátrica, Hospital Infantil La Paz, Madrid.
| | | | | | | | | | | | | |
Collapse
|
15
|
Pérez EE, Gutiérrez ME, De Delahaye EP, Tovar J, Lares M. Production and characterization of Xanthosoma sagittifolium and Colocasia esculenta flours. J Food Sci 2007; 72:S367-72. [PMID: 17995692 DOI: 10.1111/j.1750-3841.2007.00420.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
The physical proximate composition and physicochemical characteristics, microbiological stability, and in vitro alpha-amylolysis rate of flours produced by conventional dehydration techniques of the edible portions of the aroids Xanthosoma sagittifolium and Colocasia esculenta were investigated. Flours from the edible portion of both tubers did not show significant statistical differences in moisture, Aw, crude protein, total sugars, amylose, and amylopectin contents. C. esculenta flour showed higher crude fat, total, soluble, and insoluble dietary fiber, and mineral (P, Ca, Fe, and Zn) contents, whereas X. sagittifolium flour showed higher starch, ash, and reducing sugar content than its counterpart. With regard to physical and physicochemical characteristics, X. sagittifolium flour showed higher titratable acidity and relative density values, being darker and more yellowish than its counterpart. On the other hand, X. sagittifolium flour showed higher gelatinization temperature than C. esculenta flour. Parameters such as viscosity during the holding time (95 degrees C for 30 min), viscosity at 50 degrees C, setback, and consistency were lower in C. esculenta flour than X. sagittifolium flour. The viscosity peak and breakdown indexes were higher in C. esculenta flour than in the X. sagittifolium sample. The colony forming units (CFU) of the microorganisms were much lower than those reported in the literature for similar products. Moreover, due to their moisture content and water activity, these flours could be classified as dry foods and they are shelf-stable foods. The results reflect that flours with good chemical, physicochemical, and nutritional quality and satisfactory microbiological stability may be produced from these aroids.
Collapse
Affiliation(s)
- E E Pérez
- Instituto de Ciencia y Tecnología de Alimentos, Facultad de Ciencias, University Central de Venezuela.
| | | | | | | | | |
Collapse
|
16
|
Sívoli L, Michelangeli C, Pérez E, Méndez A, Tovar J. Starch digestibility and morphology of physically modified jack bean (Canavalia ensiformis L.) seed flours. Anim Feed Sci Technol 2007. [DOI: 10.1016/j.anifeedsci.2007.01.013] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
17
|
Luis A, Encinas JL, Leal N, Hernández F, Gámez M, Murcia J, López Santamaria M, Molina M, Sarriá J, Prieto G, Polanco I, Frauca E, Bartolo G, Jara P, Tovar J. [Multidisciplinary approach in the management of intestinal failure]. Cir Pediatr 2007; 20:71-4. [PMID: 17650713] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
OBJECTIVE [corrected] Our aim was to analyze our results in the management of intestinal failure with a multidisciplinary approach including optimized parenteral nutrition, reconstructive surgery and intestinal transplantation (ITx). MATERIAL AND METHODS We included all patients evaluated by our team with the diagnosis of IF. We assessed outcome, mortality and complications in children that achieved adaptation and those listed for ITx. RESULTS Seventy one children (40 boys, 31 girls) were evaluated between 1997 and 2006 because of IF. Forty eight (76%) were referred from other institutions. In 56 cases (80%) IF began in the newborn period. Causes of IF were: short bowel syndrome (52) intestinal motility disorders (16) and intestinal epithelial disorders (3). Median birth weight in the group of SBS was 2.2 Kg and prematurity was an associated condition in 15% of them. Overall, fourteen patients (20%) achieved intestinal adaptation with progressive weaning from PN, the management of these children consisted of optimized parenteral and enteral nutrition and autologous intestinal reconstructive surgery. Nine (13%) are stable under home parenteral nutrition regimen. Eight children (11%), all of them listed for liver and small bowel transplantation, died in the waiting list after a mean waiting time of more than 300 days, with a median of 4 laparotomies and 4 episodes of catheter related sepsis. Four children (5.6%) died in the adaptation process or before their inclusion on the waiting list. Finally, twenty five (35,2%) children underwent 28 intestinal transplantation: 9 isolated small bowel transplantation (SBTx), 16 combined liver and small bowel (CLSB) and 3 multivisceral (MVTx). Among transplanted patients, 9 (36%) died, (3 MVTx, 1 SBTx and 8 CLSB) and four were retransplanted. CONCLUSIONS Intestinal Transplantation is an established alternative to parenteral nutrition in the treatment of IF, although complications and mortality rates are still considerable, especially MVTx and CLSBTx. Mortality in children listed for intestinal transplantation remains also high. Intestinal adaptation can be achieved with adequate rehabilitation therapy even in some cases with apparently irreversible intestinal transplantation. Early referral before liver failure or other complications arise is crucial is crucial in order to improve the outcome of these patients.
Collapse
Affiliation(s)
- A Luis
- Departamento de Cirugía Pediátrica, Hospital Universitario la Paz, Paseo de la Castellana, 261.28046 Madrid.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Hernández-Salazar M, Agama-Acevedo E, Sáyago-Ayerdi SG, Tovar J, Bello-Pérez LA. Chemical composition and starch digestibility of tortillas prepared with non-conventional commercial nixtamalized maize flours. Int J Food Sci Nutr 2006; 57:143-50. [PMID: 16849122 DOI: 10.1080/09637480600659136] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
Non-conventional nixtamalized maize flours elaborated by a factory in Mexico were used for tortilla preparation. Tortillas were stored at 4 degrees C for up to 72 h and the total starch, available starch, resistant starch and retrograded resistant starch were assessed. The traditional white tortilla, used as a control, showed higher protein and fat contents than blue maize tortilla, whereas a maize-bean mixed tortilla had the highest protein, ash and fat contents. Lower total starch was obtained in the maize-bean tortilla than in white and blue maize tortillas. The available starch content in all tortillas decreased with the cold-storage, although the change was more marked for blue-maize tortillas. The maize-bean mixed tortillas exhibited the lowest in vitro digestibility, which is consistent with the relatively high resistant starch levels in the bean. Differences in resistant starch content were found between the two maize tortillas, which might be related to the softer texture of blue-maize tortilla. The starch digestibility features of these new types of nixtamalized maize flours open up the possibility of producing tortillas with variable nutritional properties.
Collapse
|
19
|
Romão PRT, Tovar J, Fonseca SG, Moraes RH, Cruz AK, Hothersall JS, Noronha-Dutra AA, Ferreira SH, Cunha FQ. Glutathione and the redox control system trypanothione/trypanothione reductase are involved in the protection of Leishmania spp. against nitrosothiol-induced cytotoxicity. Braz J Med Biol Res 2006; 39:355-63. [PMID: 16501815 DOI: 10.1590/s0100-879x2006000300006] [Citation(s) in RCA: 60] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Glutathione is the major intracellular antioxidant thiol protecting mammalian cells against oxidative stress induced by oxygen- and nitrogen-derived reactive species. In trypanosomes and leishmanias, trypanothione plays a central role in parasite protection against mammalian host defence systems by recycling trypanothione disulphide by the enzyme trypanothione reductase. Although Kinetoplastida parasites lack glutathione reductase, they maintain significant levels of glutathione. The aim of this study was to use Leishmania donovani trypanothione reductase gene mutant clones and different Leishmania species to examine the role of these two individual thiol systems in the protection mechanism against S-nitroso-N-acetyl-D,L-penicillamine (SNAP), a nitrogen-derived reactive species donor. We found that the resistance to SNAP of different species of Leishmania was inversely correlated with their glutathione concentration but not with their total low-molecular weight thiol content (about 0.18 nmol/10(7) parasites, regardless Leishmania species). The glutathione concentration in L. amazonensis, L. donovani, L. major, and L. braziliensis were 0.12, 0.10, 0.08, and 0.04 nmol/10(7) parasites, respectively. L. amazonensis, that have a higher level of glutathione, were less susceptible to SNAP (30 and 100 microM). The IC50 values of SNAP determined to L. amazonensis, L. donovani, L. major, and L. braziliensis were 207.8, 188.5, 160.9, and 83 microM, respectively. We also observed that L. donovani mutants carrying only one trypanothione reductase allele had a decreased capacity to survive (approximately 40%) in the presence of SNAP (30-150 microM). In conclusion, the present data suggest that both antioxidant systems, glutathione and trypanothione/trypanothione reductase, participate in protection of Leishmania against the toxic effect of nitrogen-derived reactive species.
Collapse
Affiliation(s)
- P R T Romão
- Laboratório de Imunoparasitologia, Universidade do Sul de Santa Catarina, Tubarão, SC, Brazil.
| | | | | | | | | | | | | | | | | |
Collapse
|
20
|
López-Santamaría M, Gámez M, Murcia J, Leal N, Hernández F, Tovar J, Frauca E, Camarena C, Hierro L, de la Vega A, Diaz M, Bortolo G, Jara P, Molina M, Sarriá J, Prieto G. Intestinal Transplantation in Children: Differences Between Isolated Intestinal and Composite Grafts. Transplant Proc 2005; 37:4087-8. [PMID: 16386633 DOI: 10.1016/j.transproceed.2005.10.073] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The results of the isolated intestinal grafts were compared with those of composite grafts (intestinal graft + liver) in a series of 18 transplantations performed in 17 children; 5 isolated intestinal grafts, 12 hepatointestinal grafts, and 1 multivisceral graft. Causes of intestinal failure were short bowel syndrome (n = 13), motility disorders (n = 2) and congenital epithelial disorders (n = 2). Transplantation was indicated due to end-stage liver disease (n = 14), loss of venous access (n = 2), untreatable diarrhea (n = 1) and high morbidity associated with a poor quality of life (n = 1). Six children, all with a composite graft, died after transplantation due to lymphoma (n = 2), sepsis (n = 1); intraabdominal bleeding (n = 1); pneumonia (n = 1); and overwhelming adenoviral infection (n = 1). Digestive autonomy was achieved in 16 of 18 grafts, the 11 surviving children are free of parenteral nutrition with a reasonably good quality of life. In conclusion, intestinal transplantation is a viable therapeutic alternative for children with permanent intestinal failure. The results of transplantation with an isolated intestine are clearly better that those with a composite graft.
Collapse
Affiliation(s)
- M López-Santamaría
- Unit of Pediatric Abdominal Organs Transplantation, Department of Pediatric Surgery, Madrid, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Putignani L, Tait A, Smith HV, Horner D, Tovar J, Tetley L, Wastling JM. Characterization of a mitochondrion-like organelle in Cryptosporidium parvum. Parasitology 2004; 129:1-18. [PMID: 15267107 DOI: 10.1017/s003118200400527x] [Citation(s) in RCA: 63] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Cryptosporidium parvum is a protozoan parasite that causes widespread diarrhoeal disease in humans and other animals and is responsible for large waterborne outbreaks of cryptosporidiosis. Unlike many organisms belonging to the phylum Apicomplexa, such as Plasmodium spp. and Toxoplasma gondii, there is no clinically proven drug treatment against this parasite. Aspects of the basic biology of C. parvum remain poorly understood, including a detailed knowledge of key metabolic pathways, its genome organization and organellar complement. Previous studies have proposed that C. parvum lacks a relic plastid organelle, or 'apicoplast', but that it may possess a mitochondrion. Here we characterize a mitochondrion-like organelle in C. parvum by (i) ultrastructural and morphological description (ii) localization of heterologous mitochondrial chaperonin antibody probes (iii) phylogenetic analysis of genes encoding mitochondrial transport proteins (iv) identification and analysis of mitochondrion-associated gene sequences. Our descriptive morphological analysis was performed by energy-filtering transmission electron microscopy (EFTEM) of C. hominis and C. parvum. The 'mitochondrion-like' organelle was characterized by labelling the structure with a heterologous mitochondrial chaperonin probe (hsp60) both in immunoelectron microscopy (IMEM) and immunofluorescence (IMF). Phylogenetic analysis of the mitochondrial import system and housekeeping components (hsp60 and hsp70-dnaK) suggested that the C. parvum mitochondrion-like organelle is likely to have descended from a common ancestral apicomplexan mitochondrion. We also identified a partial cDNA sequence coding for an alternative oxidase (AOX) gene, a component of the electron transport chain which can act as an alternative to the terminal mitochondrial respiratory complexes III and IV, which has not yet been reported in any other member of this phylum. Degenerate primers developed to identify selected mitochondrial genes failed to identify either cytochrome oxidase subunit I, or cytochrome b. Taken together, our data aim to provide new insights into the characterization of this Cryptosporidium organelle and a logical framework for future functional investigation.
Collapse
Affiliation(s)
- L Putignani
- Division of Infection and Immunity, Institute of Biomedical and Life Science, Joseph Black Building, University of Glasgow, Glasgow G12 8QQ, UK
| | | | | | | | | | | | | |
Collapse
|
22
|
Hernández F, López Santamaria M, Gámez M, Murcia J, Leal N, Prieto G, Molina M, Sarriá J, De Vicente E, Quijano Y, Nuño J, Frauca E, Jara P, Tovar J. [Results of an intestinal transplantation program in Spain. Five years later]. Cir Pediatr 2004; 17:145-8. [PMID: 15503953] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
Abstract
BACKGROUND More than two thirds of all intestinal transplantations (ITx) performed around the world correspondent to recipients younger than 18. OBJECTIVE To analyze our 5-year experience in pediatric ITx. PATIENTS We assessed the outcome of the 19 children included in list out of 41 patients considered for ITx from 1997. The main cause of intestinal failure was short bowel syndrome (14) followed by intestinal motility disorders (3) and congenit disorders of intestinal epithelium (CDIE) (2). The median of age, at the moment of including in the list, was 0.9 years (range 0.4-17) and median of weight was 6.4kg (range 0.4-29.3). Ten children were included for liver and small bowel transplantation (LSBTx), 7 to isolated small bowel (SBTx), and 2 for multivisceral transplantation (MVTx). Indications for SBx were hepatic fibrosis/cirrhosis (10), hepatic fibrosis in evolution (5) (to avoid later LSBTx), intractable diarrhoea (1), recurrent line infections (1), lost of central vein access (1), and bad quality of life in one. RESULTS Five children died in the waiting list, after a median time of 325 days (range 19-581). Seven remain in the waiting list (median 139 days, range 30-778). In 3 of these the indication changed from SBTx to LSBTx because of progression to end stage liver disease. Six children recieved seven grafts (1 MVTx, 4 LSBTx, 2 SBx) after a median time in the waiting list of 352 days (range 66-732). Six out of seven grafts achieved normal function and all survivals reached full digestive autonomy after Tx. We had to rejection episodes, one with good response to medical treatment and one that required removal of intestinal allograft and later LSBTx. Two children died 1 because of problem not related to the procedure (hemorrage following liver biopsy) and one girl died 29 months after transplant due to post-transplantation lymphoproliferative disease. CONCLUSIONS ITx is a realistic alternative in our country for children with intestinal failure. The main problems are immunologic (rejection, lynphoproliferative and disease) Shortage of small weight donors is a dramatic limitation that prompts the discussion of surgical alternatives.
Collapse
Affiliation(s)
- F Hernández
- Departamento de Cirugía Pediátricañ, Hospital Universitario La Paz, Madrid.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Silander K, Scott LJ, Valle TT, Mohlke KL, Stringham HM, Wiles KR, Duren WL, Doheny KF, Pugh EW, Chines P, Narisu N, White PP, Fingerlin TE, Jackson AU, Li C, Ghosh S, Magnuson VL, Colby K, Erdos MR, Hill JE, Hollstein P, Humphreys KM, Kasad RA, Lambert J, Lazaridis KN, Lin G, Morales-Mena A, Patzkowski K, Pfahl C, Porter R, Rha D, Segal L, Suh YD, Tovar J, Unni A, Welch C, Douglas JA, Epstein MP, Hauser ER, Hagopian W, Buchanan TA, Watanabe RM, Bergman RN, Tuomilehto J, Collins FS, Boehnke M. A large set of Finnish affected sibling pair families with type 2 diabetes suggests susceptibility loci on chromosomes 6, 11, and 14. Diabetes 2004; 53:821-9. [PMID: 14988269 DOI: 10.2337/diabetes.53.3.821] [Citation(s) in RCA: 63] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
The aim of the Finland-United States Investigation of NIDDM Genetics (FUSION) study is to identify genes that predispose to type 2 diabetes or are responsible for variability in diabetes-related traits via a positional cloning and positional candidate gene approach. In a previously published genome-wide scan of 478 Finnish affected sibling pair (ASP) families (FUSION 1), the strongest linkage results were on chromosomes 20 and 11. We now report a second genome-wide scan using an independent set of 242 Finnish ASP families (FUSION 2), a detailed analysis of the combined set of 737 FUSION 1 + 2 families (495 updated FUSION 1 families), and fine mapping of the regions of chromosomes 11 and 20. The strongest FUSION 2 linkage results were on chromosomes 6 (maximum logarithm of odds score [MLS] = 2.30 at 95 cM) and 14 (MLS = 1.80 at 57 cM). For the combined FUSION 1 + 2 families, three results were particularly notable: chromosome 11 (MLS = 2.98 at 82 cM), chromosome 14 (MLS = 2.74 at 58 cM), and chromosome 6 (MLS = 2.66 at 96 cM). We obtained smaller FUSION 1 + 2 MLSs on chromosomes X (MLS = 1.27 at 152 cM) and 20p (MLS = 1.21 at 20 cM). Among the 10 regions that showed nominally significant evidence for linkage in FUSION 1, four (on chromosomes 6, 11, 14, and X) also showed evidence for linkage in FUSION 2 and stronger evidence for linkage in the combined FUSION 1 + 2 sample.
Collapse
Affiliation(s)
- Kaisa Silander
- Genome Technology Branch, National Human Genome Research Institute, Bethesda, Maryland, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Leal N, López Santamaría M, Gámez M, Murcia J, López Gutiérrez JC, Larrauri J, Frauca E, Hierro L, Camarena C, de la Vega A, Díaz M, Jara P, Tovar J. [The multifocal hepatic hemangioendothelioma. Is always a benign tumor?]. Cir Pediatr 2004; 17:8-11. [PMID: 15002718] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/29/2023]
Abstract
UNLABELLED The hepatic multicentric haemangioma is defined by its extension, affecting all the mass of the liver. The high mortality associated with it is mostly related with the complications produced by its enormous size (haemodynamic, platelet trapping, spontaneous rupture and bleeding). There is a general belief that is a benign tumor with possibility of spontaneous regression and cure. AIM Retrospective analysis of our recent cases of MHH with the purpose of: 1 degrees) To show the evolution and results. 2 degrees) To realize if the "benign character" of the tumor is real or if some cases may be considered as malignant tumors. MATERIAL AND METHODS 10 cases of MHH treated in the last 10 years. In 9 the age of presentation was less than 6 months and one patient was diagnosed at 3 and half years. The diagnosis was confirmed by image techniques in 7 cases and by biopsy in 3. In 7 patients extrahepatic vascular lesions were associated prior to the treatment. Methylprednisolone was given to all the cases and alpha-2-interferon was administered to the patients that not responded to the steroids. Vincristine was added to 2 patients. In two cases the hepatic artery embolization was tried and one patient had a liver transplant. RESULTS Four children had at least one episode of congestive cardiac insufficiency, two patients suffered a consumption coagulopathy (Kasabach Merrit syndrome), and one presented acute hepatic failure. In six children it has been complete regression of the tumor, one more is still under treatment and three died. The dead were produced by the malignant behavior of the tumor in one case (tumoral rupture of a MHH recurrence in the transplanted liver), and possibly in other (intracranial haemorrhage and hepatic failure in a liver transplantation candidate without demonstrated extrahepatic extension in the previous studies, but with multiorgan dissemination at autopsy. In both cases it was impossible to discover signs of histologic or biologic malignancy neither in the primitive lesion nor in the metastasis. CONCLUSIONS 1a) The regression of the MHH, spontaneous or induced by the treatment is frequent. 2a) Some cases of MHH are aggressive and develop local recurrences and distant metastasis. 3a) The discrimination between MHH of "benign" or "malignant" behaviour is not possible. 4a) Despite of the unpredictable biological conduct of the tumor, the liver transplantation must be considered as an option in the symptomatic cases that not respond to the conventional treatment.
Collapse
Affiliation(s)
- N Leal
- Departamento de Cirugía Pediátrica, Hospital Infantil "La Paz", Madrid
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
López Santamaría M, Gámez M, Murcia J, Díez Pardo JA, Leal N, Frauca E, Camarena C, Hierro L, de la Vega A, Díaz MC, Jara P, Tovar J. [Prognostic factors in pediatric liver transplantation. Multivariate analysis]. Cir Pediatr 2003; 16:175-80. [PMID: 14677355] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
Abstract
AIM To analyze independent risk factors associated with poor graft and patient survival in a series of 292 pediatric liver transplants (PLT) performed in 234 children during a 15 years period. MATERIAL AND METHODS. 1. Univariate graft and patient survival analysis in 45 variables related to pretransplant patient status, surgical technique and donor conditions. 2. Variables found with univariate analysis to be associated with outcome were entered into a stepwise backward proportional hazard model (Cox), to determine independent prediction of outcome. RESULTS 11 variables influence the graft survival: recipient age, z-score recipient height, UNOS status, recipient and donor weight, transplant for immune hepatitis, platelet transfusion during the transplant, blood index > 4 during the surgery, type of arterial reconstruction, retransplantation and era of the transplant (first er: 1986-1990; 2nd. era: 1991-1995; 3rd. era: 1996-2000). Four of those variables are independent in the multivariate analysis: UNOS 1 status (Odds Ratio, OR = 2.82, 95% confidence interval = 1.36-5.85), recipient < 3 years (OR = 3.76, 95% CI = 2.13-6.63), transplants for autoimmune hepatitis and era (OR of first and second versus third era respectively 3.93 and 2.81). The independent variables influencing the patient survival were: children receiving more than one graft children less than 3 years old and transplant era. CONCLUSIONS Liver transplant in small children is associated with an increased risk of graft loss and patient dead. The experience of the hospital in pediatric liver transplantation improves the results, particularly in small children.
Collapse
Affiliation(s)
- M López Santamaría
- Unidad de Trasplantes Digestivos, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046 Madrid
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Tovar J, Sáyago-Ayerdi SG, Peñalver C, Paredes-López O, Bello-Pérez LA. In Vitro Starch Hydrolysis Index and Predicted Glycemic Index of Corn Tortilla, Black Beans (Phaseolus vulgarisL.), and Mexican “taco”. Cereal Chem 2003. [DOI: 10.1094/cchem.2003.80.5.533] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Affiliation(s)
- J. Tovar
- Instituto de Biología Experimental, Facultad de Ciencias, Universidad Central de Venezuela, Apartado Postal 47069, Caracas 1041-A, Venezuela
| | - S. G. Sáyago-Ayerdi
- Instituto Tecnológico de Acapulco, Av. Instituto Tecnológico s/n, Crucero Cayaco-Puerto Marques, C.P. 39905, Acapulco, Guerrero, México
| | - C. Peñalver
- Instituto de Biología Experimental, Facultad de Ciencias, Universidad Central de Venezuela, Apartado Postal 47069, Caracas 1041-A, Venezuela
| | - O. Paredes-López
- Centro de Investigación y Estudios Avanzados del IPN, Unidad Irapuato, Apartado Postal 629, 36500, Irapuato, Guanajuato, México
| | - L. A. Bello-Pérez
- Instituto Tecnológico de Acapulco, Av. Instituto Tecnológico s/n, Crucero Cayaco-Puerto Marques, C.P. 39905, Acapulco, Guerrero, México
- Centro de Desarrollo de Productos Bióticos del IPN. Km 8.5 carr. Yautepec-Jojutla, colonia San Isidro, apartado postal 24, 62731 Yautepec, Morelos, México
- Corresponding author. E-mail: . Fax: +5273941896
| |
Collapse
|
27
|
López-Santamaria M, de Vicente E, Gámez M, Murcia M, Leal N, Hernandez F, Nuño J, Frauca E, Camarena C, Hierro L, de la Vega A, Bortolo G, Diaz M, Jara P, Tovar J. Pediatric living donor liver transplantation. Transplant Proc 2003; 35:1808-9. [PMID: 12962803 DOI: 10.1016/s0041-1345(03)00570-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
AIM The aim of this study was to analyze the results of living donor in a pediatric liver transplantation program. PATIENTS Twenty-six living donor liver transplantations were performed in children from 0.5 to 14.8 years of age. The main indication was biliary atresia (72%) followed by tumors (2 hepatoblastomas and 1 hepatocarcinoma). Left lateral segments were used in 23 (1 transformed into a monosegment), 1 left lobe was used in 1, and right lobes were used in 2. Arterial reconstruction employed saphenous venous grafts in the first 3 cases and end-to-end anastomoses with a microsurgical technique in the following 22 cases. RESULTS There has been no major morbidity in the donors, with a median hospitalization of 6 days. Four grafts have been lost; 2 in the first 3 cases. In only 1 case, the graft loss was related to the procedure saphenous venous graft thrombosis). Early biliary complications were frequent (23%). Six month, 1 year, and 5 year graft and patient survival rates were 91%, 85%, and 85% and 100%, 96%, and 96%, respectively. CONCLUSIONS Living donor liver transplantation is an excellent option for transplantation in children.
Collapse
Affiliation(s)
- M López-Santamaria
- Unit of Pediatric Liver Transplantation, Department of Pediatric Surgery, La Paz University Hospital, Madrid, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
López-Santamaría M, Gámez M, Murcia M, Leal N, Hernandez F, de Vicente E, Quijano Y, Prieto G, Frauca E, Sarriá J, Molina M, Polanco I, Jara P, Tovar J. Pediatric intestinal transplantation. Transplant Proc 2003; 35:1927-8. [PMID: 12962851 DOI: 10.1016/s0041-1345(03)00727-9] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
AIM Analyze the results of a paediatric intestinal transplantation (IT) program in Spain. PATIENTS During an 5-year period, 18 children were included as candidates for IT. The causes for intestinal failure (IF) were short bowel syndrome (n=13), motility disorders (n=3), and congenital epithelial disorders (n=2). Nine children were admitted for a combined liver-small bowel transplant (LSBT), seven for an isolated intestinal transplantation (IIT) and two for a multivisceral transplantation (MVT). In three of the candidates for IIT the indication had to be changed to LSBT because of progression of the liver damage. RESULTS Eight candidates are on the waiting list: four for LSBT, two for IIT, and two for MVT. Four children died before transplantation. All were children under 1 year and candidates for LSBT. One child died during an attempted MVT. Five children underwent transplantation. Grafts were IIT in two and LSBT in three. Of these children, two are on a normal diet (respective follow-up times: 40 and 18 months), two died, both with functioning liver and intestinal grafts (hemorrage after liver biopsy and lymphoproliferative disease), and one developed an untreatable rejection that lead to loss of the intestinal graft; currently, she is on the waiting list for LSBT. CONCLUSIONS The morbidity and mortality of IT are high, but it is the only possible treatment for children in IF who cannot be adequately managed with parenteral nutrition. A severe problem is the the scarcity of suitable donors for the very low weight children who are candidates for LSBT.
Collapse
Affiliation(s)
- M López-Santamaría
- Unit of Pediatric Liver Transplantation, Department of Pediatric Surgery, La Paz University Hospital, Madrid, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
López Santamaría M, Gámez M, Murcia J, Leal N, de Vicente E, Quijano Y, Nuño J, Larrauri J, Frauca E, Molina M, Sarriá J, Prieto G, Lama R, Jara P, Polanco I, Tovar J. [Activity of a pediatric intestinal transplantation program in Spain]. Cir Pediatr 2003; 16:142-5. [PMID: 14565096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
Abstract
AIM To analyze the outcome of children with intestinal failure (IF) included as candidates for intestinal transplantation (IT). Patients, Eight out of 23 children with IF assessed since July 1997 met criteria for IT and were included on the waiting list. The causes of IT were Short Bowel Syndrome (SBS) in 6 and Microvillus Inclusion Disease (MID) in 2. The indication of IT were end stage liver disease (ESLD) in 5 (related to total parenteral nutrition administration, TPN), progressive hepatic fibrosis in 2 and loss of venous access in 1. The patients with ESLD were included for combined liver-small bowel transplantation (LSBT) and the remaining for isolated intestinal transplantation (IIT). RESULTS Two children died waiting for LSBT, 4 patients are on the waiting list, 2 for LSBT and 2 for IIT (length of stay: 4-11 months). Two children were transplanted, one with IIT in a 2.5 years old boy with MID, and one with LSBT in a 22 months girl with SBS and ESLD. Both patients recovered intestinal function after transplantation and are a live (follow-up of 19 and 10 months respectively). The LSBT's patient is under treatment for postransplant lymphoproliferative disease (PTLD). CONCLUSIONS The lack of suitable donors for the small children candidate to IT explains the long period of stay on the waiting list and the high pretransplant mortality. Two strategies are possible; early referral of children with IF to a transplant center and surgical techniques like ex vivi-hepatic reductions of the LSB graft.
Collapse
Affiliation(s)
- M López Santamaría
- Unidad de Trasplantes Digestivos, Hospital Universitario La Paz, Paseo de la Castellana, 261, 28046 Madrid
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Osorio-Dı́az P, Bello-Pérez L, Agama-Acevedo E, Vargas-Torres A, Tovar J, Paredes-López O. In vitro digestibility and resistant starch content of some industrialized commercial beans (Phaseolus vulgaris L.). Food Chem 2002. [DOI: 10.1016/s0308-8146(02)00117-6] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
31
|
Leal N, López Santamaría M, Gámez M, Murcia J, Andolfi G, Berrocal T, Frauca E, Jara P, Tovar J. [Mesenteric-cava shunt's results with autologous jugular vein graft in children with pre-sinusoidal portal hypertension]. Cir Pediatr 2002; 15:114-7. [PMID: 12601985] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/01/2023]
Abstract
UNLABELLED Presinusoidal portal hypertension (PPH) in children evaluates without functional hepatic damage, and with the time, trends to compensate through the creation of spontaneous portosystemic shunts. Nevertheless, some patients suffer episodes of gastrointestinal bleeding (GIB) that because of its frequency or severity, force to propose the change of surgical treatment. AIM To evaluate the results of the mesocaval shunt (MCS) with autologous jugular vein in children with PPH. MATERIAL AND METHODS Among the 32 children with PPH treated in our Hospital in the last 7 years, 10 had episodes of GIB that forced to perform a surgical shunt. The types of shunt were distal splenorenal in 3 patients and mesocaval in 7. These 7 cases are the material of this study. The origin of the PPH was a cavernomatosis transformation of the portal vein in 6 cases and a congenital hepatic fibrosis in 1. Before the surgery the average number of episodes of GIB was 9 (range 2-15); all the patients needed transfusion of blood products and variceal sclerosis. In 2 cases a tamponade with the Sengtaken balloon was required and 5 patients were treated with somatostatin and propranolol. The Doppler ultrasounds revealed and intense hepatofugal collateral circulation in all the cases. RESULTS The initial flow through the shunt was adequate in all the patients except one who required a percutaneous balloon dilatation. Only this patient has suffered an episode of GIB. The hyperesplenism signs disappeared or improved in all the seven cases and the collateral circulation was significantly reduced. The pressure in the splenic territory decreased around 50% in the 4 patients that was measured. There were no cases of encephalopasty and only one child with congenital hepatic fibrosis shows signs of mild hepatic disfunction. The medium follow up post-shunt is 32 months (range 8 m-6 years). CONCLUSIONS The MCS prevents the GIB in the PPH not responsive to the conservative treatment; its effectiveness is related with an adequate permeability though the graft and at least in the cases with portal cavernomatosis (the most frequent in children) doesn't produce hepatic dysfunction. Doppler ultrasounds give a very precise information about the post-surgical situation and are an excellent method of follow up.
Collapse
Affiliation(s)
- N Leal
- Departamento de Cirugía Pediátrica, Hospital Infantil La Paz, Paseo de la Castellana, 261, 28046 Madrid
| | | | | | | | | | | | | | | | | |
Collapse
|
32
|
López-Santamaria M, Gámez M, Murcia J, Leal N, Tovar J, Prieto G, Molina M, Sarriá J, Polanco I, Larrauri J, Frauca E, Jara P, Vicente EDE, Quijano Y, Nuño J. Outcome of children with intestinal failure included as candidates for intestinal transplantation in Spain. Transplant Proc 2002; 34:881. [PMID: 12034219 DOI: 10.1016/s0041-1345(02)02651-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- M López-Santamaria
- Hospital Universitario La Paz, Madrid Dto de Cirugía Pediátrica, Unidad de Trasplantes Digestivos, Madrid, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
López-Santamaria M, Gámez M, Murcia J, Leal N, Tovar J, Prieto G, Lama R, Molina M, Sarriá J, Polanco I, Larrauri J, Frauca E, Jara P, De Vicente E, Quijano Y, Nuño J. Intestinal transplantation: the Spanish experience. Transplant Proc 2002; 34:220. [PMID: 11959255 DOI: 10.1016/s0041-1345(01)02733-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- M López-Santamaria
- Hospital Universitario, La Paz, Madrid Dto de Cirugía Pediátrica, Unidad de Trasplantes Digestivos, Madrid, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
34
|
López-Santamaria M, Gámez M, Murcia J, Leal N, Tovar J, Frauca E, Jara P, De Vicente E, Quijano Y, Nuno J. Do the results justify living donor and split liver transplant for children in Spain? Transplant Proc 2002; 34:239. [PMID: 11959263 DOI: 10.1016/s0041-1345(01)02741-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- M López-Santamaria
- Hospital Universitario La Paz, Madrid, Dto de Cirugía Pediátrica, Unidad de Trasplantes Digestivos, Madrid, Spain.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
López-Santamaria M, Gámez M, Murcia J, Leal N, Tovar J, Prieto G, Lama R, Molina M, Sarria J, Polanco I, Larrauri J, Frauca E, Jara P. Children with intestinal failure evaluated for intestinal transplantation in Spain. Transplant Proc 2002; 34:219. [PMID: 11959254 DOI: 10.1016/s0041-1345(01)02732-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Affiliation(s)
- M López-Santamaria
- Department of Pediatric Surgery, Hospital Infantil La Paz, Madrid, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
López Santamaría M, Gámez M, Murcia J, Frauca E, Hierro L, Camarena C, de la Vega A, Díaz M, Jara P, Prieto C, Berrocal T, Garzón G, Tovar J. [Pre-hepatic portal hypertension as a late complication of liver transplantation in children]. Cir Pediatr 2001; 14:135-8. [PMID: 12601959] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/01/2023]
Abstract
UNLABELLED In the long-term after liver transplantation (LT), some children develop prehepatic portal hypertension (PPH) and raise problems not very well known yet; many of the lessons learned with the management of these patients may be useful outside the LT. AIM 1. To analyze the incidence and risk factors of PPH after LT. 2. To evaluate the results with the different treatments used. METHODS Retrospective study over 164 children surviving more than 1 year after LT. Univariant analysis of possible risk factors associated and multivariant (logistic regression), for those that had significance in the univariant analysis. Other factors associated are analyzed as well as the indications and results of two types of treatment: percutaneous pneumatic dilatation and surgical shunt (splenorenal and Rex shunt). RESULTS 9 children developed symptomatic PPH (hemorrhage in 8, ascites in 1), associated to lymphoproliferative post-LT disease in 2, and to anastomotic biliary stricture in 1. The age at first LT (children under 1 year old), weight (below 10 kg), and need of retransplantation (reLT) were in the univariant analysis the associated variables with increased risk of PPH. The diagnosis (biliary atresia) and the emergency status of the LT were almost significative. In the multivariant analysis, the need of reLT is the only independent variable that increases the risk (relative risk: 4.5, confidence interval 95%: 1.29-18.87). At diagnosis 3 cases showed portal estenosis, and 5 showed absence of permeability with cavernomatous transformation. The PPH was caused in one case because of the esplenic vein disconnection (treatment not required at the moment); the three cases of portal estenosis were dilated percutaneously with success, and 2 of the 5 cases with portal thrombosis have been surgically shunted: one by an splenorenal shunt and the other by a Rex shunt (first case done in Spain); the other 3 cases are stable waiting for a surgical solution. The hepatic function is normal in the 9 cases. CONCLUSIONS The PPH can complicate the prognostic of the pediatric LT in the long term. The treatment depends on the permeability of the portal trunk. Whenever possible, percutaneous dilatation should be attempted; should surgery be required, the Rex shunt is the best option.
Collapse
Affiliation(s)
- M López Santamaría
- Dpto. de Cirugía Pediátrica, Unidad de Trasplantes Digestivos, Hospital Universitario La Paz, Madrid
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Murcia J, López Santamaría M, Gámez M, Hierro L, Frauca E, Camarena C, de la Vega A, Díaz M, Jara P, Tovar J. [Liver transplantation in infants younger than one year of age]. Cir Pediatr 2001; 14:121-3. [PMID: 11547633] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
Abstract
BACKGROUND The development of the surgical techniques of hepatic division has maken that the young age (less than one year old) is no longer considered a risk factor in the pediatric liver transplant (TH). AIM To show our experience with the TH in children younger than one year, comparing these results with the rest of the series and in second place to analyze if a bigger experience improves the results of the TH in this group of patients. METHODS 44 patients that received a TH with less than a year of age are reviewed. Among them, 27 were in the last five years. The survival indexes of the graft and the patient are determined at 1, 5 and 10 years comparing them with three rest of the series. RESULTS The grafts and patients survival was slightly inferior in the less than one year old, although in the last five years it improved 71.4% vs 82.1% at one year follow-up, and 61.9 in front of 74.5% at five years. The clinical situation of the patients that were transplanted before the year of life was worse: 43% (UNOS III, IV) in front of 13.1% in the same stadiums in the rest of the serie. In the younger patients, 54% of the grafts were reduced, versus 21% in the older. There were not a higher rate of complications in the young group. CONCLUSIONS In spite of the difficulties of the TH in children younger than one year of age, the results are not very different from those obtained in the rest of the patients. In these results the experience of the transplant center have a great influence.
Collapse
Affiliation(s)
- J Murcia
- Departamento de Cirugía, Hospital Infantil La Paz, Madrid
| | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Murcia J, López Santamaría M, Gámez M, Hierro L, Frauca E, Camarena C, de la Vega A, Díaz M, Jara P, Tovar J. [Prognosis in children with biliary atresia successfully treated with Kasai's operation]. Cir Pediatr 2001; 14:66-8. [PMID: 11480194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/20/2023]
Abstract
BACKGROUND The Kasai procedure, portoenteroanastomosis (PEA) didn't reach international spreading until the seventy's decade, making difficult to find long-term results from children with ABE successfully treated with this technique. At our institution in the last fifteen years all the therapeutics procedures for these patients can be offered, including the liver transplant. AIM To show the evolution of our patients with ABE treated with the PEA and that survive long-term without being transplanted. METHODS The clinical course of 22 patients that survive more than 10 years after the PEA with their own liver is reviewed. The hepatic survival indexes of (success, death or transplant) are beyond the tenth year. The problems raised during the follow-up are analysed. RESULTS From 99 patients with ABE treated primarily in our center, 22 reached the 10 year-old age after the PEA without a liver transplant. In the follow-up, seven if the these finally needed the transplant. Their median age was 12.2 year-old (range: 10.5-13.8) for a progressive hepatocellular damage in 5 cases associated to syndrome hepatopulmonar in two cases. The other fifteen patients have a compensated hepatopathy. Five of them do not have hyperesplenisme and the serum bilirrubine levels are lower than 1.3 mg/dL. The medium age of these patients at the end of the follow-up was 14.8 years. CONCLUSIONS In spite of the reestablishment of the biliary flow with the PEA, few are the patients with ABE that preserve their hepatic function lapsed long periods of time. Nevertheless the prognosis of these patients is excellent.
Collapse
Affiliation(s)
- J Murcia
- Departamento de Cirugía, Hospital Infantil La Paz, Madrid
| | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
López Santamaría M, de Vicente E, Gámez M, Murcia J, Migliazza L, Quijano Y, Nuño J, Larrauri J, Frauca E, Molina M, Sarriá J, Prieto G, Jara P, Polanco I, Tovar J. [Intestinal transplantation. First experience in Spain]. Cir Pediatr 2001; 14:25-7. [PMID: 11339115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/20/2023]
Abstract
UNLABELLED We present the first case of intestinal transplant (IT) performed in Spacin. CASE REPORT 28 months old boy with secretory diarrhea since the first month of life, diagnosed of microvillous inclusion disease (MID). He is on total parenteral nutrition (TPN) and had suffered of multiple episodes of catheter related sepsis with lost of standard venous access. An isolated small bowel transplant from a cadaveric donor was performed at the age of 3 years. The native ileocaecal valve and colon were not removed. RESULTS Enteral feeding was started in the 2nd. week after the IT. On the 25th day he was off TPN. Since the 77th day, he eats regular foods by mouth. At the 6th month post IT the ileostomy was closed. Among the complications, he suffered a rotavirus infection on the 38th post IT day and an episode of mild rejection responsive to methil-prednisolone bolus. CONCLUSIONS The IT is a therapeutic option that can be already offered with possibilities of success in our country. Although the colonic enterocytes express MVD, the recipient ileocaecal valve and colon can be preserved.
Collapse
Affiliation(s)
- M López Santamaría
- Dpto. de Cirugía Pediátrica, Unidad de Trasplantes Digestivos, Hospital Universitario, La Paz, Madrid
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Ghosh S, Watanabe RM, Valle TT, Hauser ER, Magnuson VL, Langefeld CD, Ally DS, Mohlke KL, Silander K, Kohtamaki K, Chines P, Balow, Jr. J, Birznieks G, Chang J, Eldridge W, Erdos MR, Karanjawala ZE, Knapp JI, Kudelko K, Martin C, Morales‐Mena A, Musick A, Musick T, Pfahl C, Porter R, Rayman JB, Rha D, Segal L, Shapiro S, Sharaf R, Shurtleff B, So A, Tannenbaum J, Te C, Tovar J, Unni A, Welch C, Whiten R, Witt A, Blaschak‐Harvan J, Douglas JA, Duren WL, Epstein MP, Fingerlin TE, Kaleta HS, Lange EM, Li C, McEachin RC, Stringham HM, Trager E, White PP, Eriksson J, Toivanen L, Vidgren G, Nylund SJ, Tuomilehto‐Wolf E, Ross EH, Demirchyan E, Hagopian WA, Buchanan TA, Tuomilehto J, Bergman RN, Collins FS, Boehnke M. The Finland–United States Investigation of Non–Insulin‐Dependent Diabetes Mellitus Genetics (FUSION) Study. I. An Autosomal Genome Scan for Genes That Predispose to Type 2 Diabetes. Am J Hum Genet 2000. [DOI: 10.1086/321185] [Citation(s) in RCA: 41] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
|
41
|
Watanabe RM, Ghosh S, Langefeld CD, Valle TT, Hauser ER, Magnuson VL, Mohlke KL, Silander K, Ally DS, Chines P, Blaschak‐Harvan J, Douglas JA, Duren WL, Epstein MP, Fingerlin TE, Kaleta HS, Lange EM, Li C, McEachin RC, Stringham HM, Trager E, White PP, Balow, Jr. J, Birznieks G, Chang J, Eldridge W, Erdos MR, Karanjawala ZE, Knapp JI, Kudelko K, Martin C, Morales‐Mena A, Musick A, Musick T, Pfahl C, Porter R, Rayman JB, Rha D, Segal L, Shapiro S, Sharaf R, Shurtleff B, So A, Tannenbaum J, Te C, Tovar J, Unni A, Welch C, Whiten R, Witt A, Kohtamaki K, Ehnholm C, Eriksson J, Toivanen L, Vidgren G, Nylund SJ, Tuomilehto‐Wolf E, Ross EH, Demirchyan E, Hagopian WA, Buchanan TA, Tuomilehto J, Bergman RN, Collins FS, Boehnke M. The Finland–United States Investigation of Non–Insulin‐Dependent Diabetes Mellitus Genetics (FUSION) Study. II. An Autosomal Genome Scan for Diabetes‐Related Quantitative‐Trait Loci. Am J Hum Genet 2000. [DOI: 10.1086/321184] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
42
|
Ghosh S, Watanabe RM, Valle TT, Hauser ER, Magnuson VL, Langefeld CD, Ally DS, Mohlke KL, Silander K, Kohtamäki K, Chines P, Balow J, Birznieks G, Chang J, Eldridge W, Erdos MR, Karanjawala ZE, Knapp JI, Kudelko K, Martin C, Morales-Mena A, Musick A, Musick T, Pfahl C, Porter R, Rayman JB, Rha D, Segal L, Shapiro S, Sharaf R, Shurtleff B, So A, Tannenbaum J, Te C, Tovar J, Unni A, Welch C, Whiten R, Witt A, Blaschak-Harvan J, Douglas JA, Duren WL, Epstein MP, Fingerlin TE, Kaleta HS, Lange EM, Li C, McEachin RC, Stringham HM, Trager E, White PP, Eriksson J, Toivanen L, Vidgren G, Nylund SJ, Tuomilehto-Wolf E, Ross EH, Demirchyan E, Hagopian WA, Buchanan TA, Tuomilehto J, Bergman RN, Collins FS, Boehnke M. The Finland–United States Investigation of Non–Insulin-Dependent Diabetes Mellitus Genetics (FUSION) Study. I. An Autosomal Genome Scan for Genes That Predispose to Type 2 Diabetes. Am J Hum Genet 2000. [DOI: 10.1016/s0002-9297(07)62948-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
43
|
Ghosh S, Watanabe RM, Valle TT, Hauser ER, Magnuson VL, Langefeld CD, Ally DS, Mohlke KL, Silander K, Kohtamäki K, Chines P, Balow, Jr. J, Birznieks G, Chang J, Eldridge W, Erdos MR, Karanjawala ZE, Knapp JI, Kudelko K, Martin C, Morales-Mena A, Musick A, Musick T, Pfahl C, Porter R, Rayman JB, Rha D, Segal L, Shapiro S, Sharaf R, Shurtleff B, So A, Tannenbaum J, Te C, Tovar J, Unni A, Welch C, Whiten R, Witt A, Blaschak-Harvan J, Douglas JA, Duren WL, Epstein MP, Fingerlin TE, Kaleta HS, Lange EM, Li C, McEachin RC, Stringham HM, Trager E, White PP, Eriksson J, Toivanen L, Vidgren G, Nylund SJ, Tuomilehto-Wolf E, Ross EH, Demirchyan E, Hagopian WA, Buchanan TA, Tuomilehto J, Bergman RN, Collins FS, Boehnke M. The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes. Am J Hum Genet 2000; 67:1174-85. [PMID: 11032783 PMCID: PMC1288560] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2000] [Accepted: 08/17/2000] [Indexed: 02/17/2023] Open
Abstract
We performed a genome scan at an average resolution of 8 cM in 719 Finnish sib pairs with type 2 diabetes. Our strongest results are for chromosome 20, where we observe a weighted maximum LOD score (MLS) of 2.15 at map position 69.5 cM from pter and secondary weighted LOD-score peaks of 2.04 at 56.5 cM and 1.99 at 17.5 cM. Our next largest MLS is for chromosome 11 (MLS = 1.75 at 84.0 cM), followed by chromosomes 2 (MLS = 0.87 at 5.5 cM), 10 (MLS = 0.77 at 75.0 cM), and 6 (MLS = 0.61 at 112.5 cM), all under an additive model. When we condition on chromosome 2 at 8.5 cM, the MLS for chromosome 20 increases to 5.50 at 69.0 cM (P=.0014). An ordered-subsets analysis based on families with high or low diabetes-related quantitative traits yielded results that support the possible existence of disease-predisposing genes on chromosomes 6 and 10. Genomewide linkage-disequilibrium analysis using microsatellite marker data revealed strong evidence of association for D22S423 (P=.00007). Further analyses are being carried out to confirm and to refine the location of these putative diabetes-predisposing genes.
Collapse
Affiliation(s)
- Soumitra Ghosh
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Richard M. Watanabe
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Timo T. Valle
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Elizabeth R. Hauser
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Victoria L. Magnuson
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Carl D. Langefeld
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Delphine S. Ally
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Karen L. Mohlke
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Kaisa Silander
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Kimmo Kohtamäki
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Peter Chines
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - James Balow, Jr.
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Gunther Birznieks
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Jennie Chang
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - William Eldridge
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Michael R. Erdos
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Zarir E. Karanjawala
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Julie I. Knapp
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Kristina Kudelko
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Colin Martin
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Anabelle Morales-Mena
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Anjene Musick
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Tiffany Musick
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Carrie Pfahl
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Rachel Porter
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Joseph B. Rayman
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - David Rha
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Leonid Segal
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Shane Shapiro
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Ravi Sharaf
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Ben Shurtleff
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Alistair So
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Joyce Tannenbaum
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Catherine Te
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Jason Tovar
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Arun Unni
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Christian Welch
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Ray Whiten
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Alyson Witt
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Jillian Blaschak-Harvan
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Julie A. Douglas
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - William L. Duren
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Michael P. Epstein
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Tasha E. Fingerlin
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Hong Shi Kaleta
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Ethan M. Lange
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Chun Li
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Richard C. McEachin
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Heather M. Stringham
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Edward Trager
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Peggy P. White
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Johan Eriksson
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Liisa Toivanen
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Gabriele Vidgren
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Stella J. Nylund
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Eva Tuomilehto-Wolf
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Edna H. Ross
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Elza Demirchyan
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - William A. Hagopian
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Thomas A. Buchanan
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Jaakko Tuomilehto
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Richard N. Bergman
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Francis S. Collins
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Michael Boehnke
- Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| |
Collapse
|
44
|
Gorospe L, Fernández-Gil MA, Torres I, Tovar J, García-Miguel P, Tejerina E. Misleading lead: inflammatory pseudotumor of the mediastinum with digital clubbing. Med Pediatr Oncol 2000; 35:484-7. [PMID: 11070481 DOI: 10.1002/1096-911x(20001101)35:5<484::aid-mpo7>3.0.co;2-t] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Affiliation(s)
- L Gorospe
- Department of Radiology, "La Paz" University Hospital, Madrid, Spain.
| | | | | | | | | | | |
Collapse
|
45
|
Watanabe RM, Ghosh S, Langefeld CD, Valle TT, Hauser ER, Magnuson VL, Mohlke KL, Silander K, Ally DS, Chines P, Blaschak-Harvan J, Douglas JA, Duren WL, Epstein MP, Fingerlin TE, Kaleta HS, Lange EM, Li C, McEachin RC, Stringham HM, Trager E, White PP, Balow, Jr. J, Birznieks G, Chang J, Eldridge W, Erdos MR, Karanjawala ZE, Knapp JI, Kudelko K, Martin C, Morales-Mena A, Musick A, Musick T, Pfahl C, Porter R, Rayman JB, Rha D, Segal L, Shapiro S, Sharaf R, Shurtleff B, So A, Tannenbaum J, Te C, Tovar J, Unni A, Welch C, Whiten R, Witt A, Kohtamäki K, Ehnholm C, Eriksson J, Toivanen L, Vidgren G, Nylund SJ, Tuomilehto-Wolf E, Ross EH, Demirchyan E, Hagopian WA, Buchanan TA, Tuomilehto J, Bergman RN, Collins FS, Boehnke M. The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. II. An autosomal genome scan for diabetes-related quantitative-trait loci. Am J Hum Genet 2000; 67:1186-200. [PMID: 11032784 PMCID: PMC1288561] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2000] [Accepted: 08/17/2000] [Indexed: 02/17/2023] Open
Abstract
Type 2 diabetes mellitus is a complex disorder encompassing multiple metabolic defects. We report results from an autosomal genome scan for type 2 diabetes-related quantitative traits in 580 Finnish families ascertained for an affected sibling pair and analyzed by the variance components-based quantitative-trait locus (QTL) linkage approach. We analyzed diabetic and nondiabetic subjects separately, because of the possible impact of disease on the traits of interest. In diabetic individuals, our strongest results were observed on chromosomes 3 (fasting C-peptide/glucose: maximum LOD score [MLS] = 3.13 at 53.0 cM) and 13 (body-mass index: MLS = 3.28 at 5.0 cM). In nondiabetic individuals, the strongest results were observed on chromosomes 10 (acute insulin response: MLS = 3.11 at 21.0 cM), 13 (2-h insulin: MLS = 2.86 at 65.5 cM), and 17 (fasting insulin/glucose ratio: MLS = 3.20 at 9.0 cM). In several cases, there was evidence for overlapping signals between diabetic and nondiabetic individuals; therefore we performed joint analyses. In these joint analyses, we observed strong signals for chromosomes 3 (body-mass index: MLS = 3.43 at 59.5 cM), 17 (empirical insulin-resistance index: MLS = 3.61 at 0.0 cM), and 19 (empirical insulin-resistance index: MLS = 2.80 at 74.5 cM). Integrating genome-scan results from the companion article by Ghosh et al., we identify several regions that may harbor susceptibility genes for type 2 diabetes in the Finnish population.
Collapse
Affiliation(s)
- Richard M. Watanabe
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Soumitra Ghosh
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Carl D. Langefeld
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Timo T. Valle
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Elizabeth R. Hauser
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Victoria L. Magnuson
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Karen L. Mohlke
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Kaisa Silander
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Delphine S. Ally
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Peter Chines
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Jillian Blaschak-Harvan
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Julie A. Douglas
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - William L. Duren
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Michael P. Epstein
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Tasha E. Fingerlin
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Hong Shi Kaleta
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Ethan M. Lange
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Chun Li
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Richard C. McEachin
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Heather M. Stringham
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Edward Trager
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Peggy P. White
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - James Balow, Jr.
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Gunther Birznieks
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Jennie Chang
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - William Eldridge
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Michael R. Erdos
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Zarir E. Karanjawala
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Julie I. Knapp
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Kristina Kudelko
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Colin Martin
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Anabelle Morales-Mena
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Anjene Musick
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Tiffany Musick
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Carrie Pfahl
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Rachel Porter
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Joseph B. Rayman
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - David Rha
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Leonid Segal
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Shane Shapiro
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Ravi Sharaf
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Ben Shurtleff
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Alistair So
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Joyce Tannenbaum
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Catherine Te
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Jason Tovar
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Arun Unni
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Christian Welch
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Ray Whiten
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Alyson Witt
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Kimmo Kohtamäki
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Christian Ehnholm
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Johan Eriksson
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Liisa Toivanen
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Gabriele Vidgren
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Stella J. Nylund
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Eva Tuomilehto-Wolf
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Edna H. Ross
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Elza Demirchyan
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - William A. Hagopian
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Thomas A. Buchanan
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Jaakko Tuomilehto
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Richard N. Bergman
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Francis S. Collins
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| | - Michael Boehnke
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor; Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda; Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki; Department of Physiology and Biophysics and Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles; and Department of Medicine, University of Washington, Seattle
| |
Collapse
|
46
|
Leal N, López JC, Díaz M, Ros Z, Pérez Alonso P, Tovar J. [Congenital fibrosarcoma. Diagnostic-therapeutic implications]. Cir Pediatr 2000; 13:156-8. [PMID: 12601952] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/01/2023]
Abstract
Most of the soft tissue sarcomas of childhood other than rabdomyosarcoma, have as final diagnosis fibrosarcoma, specially in the first months of life. Overlapping features between infantile myofibromatosis and congenital fibrosarcoma, hemangiopericytoma and fibrohistiocytoma have seen noted. Five patients with congenital fibrosarcoma were operated since 1991. Anatomical sites included lower limb, hand and forearm, and three of them had previous diagnoses of hemangiopericytoma, fibrohistiocytoma and myofibromatosis, with provocated non radical surgery and reoperation. The postoperative course was satisfactory and all are live one to eight years later. In our experience accurate histological diagnosis must be achieved to perform radical surgery on these cases.
Collapse
Affiliation(s)
- N Leal
- Departamento de Cirugía Pediátrica, Hospital Infantil, La Paz, Paseo de la Castellana 261, 28046 Madrid
| | | | | | | | | | | |
Collapse
|
47
|
López Santamaría M, Gámez M, Murcia J, Migliazza L, Clavijo J, Tovar J, Frauca E, Lama R, Sarriá J, Prieto G, Polanco I. [Children with intestinal failure as candidates for intestinal transplantation]. Cir Pediatr 2000; 13:116-20. [PMID: 12601941] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/20/2023]
Abstract
Small bowel is not anymore considered a forbidden organ for transplantation, and intestinal transplantation (IT) is currently used as a therapeutic option in selected cases of permanent intestinal failure (PIF). Nevertheless, the experience is still scarce, and despite recent improvements, IT is nowadays only accepted as a life-saving option. However, small children are prone to suffer complications related to TPN, particularly end stage liver disease; moreover, suitable donor for the small baby who needs an IT is seldom available. Subsequently, a high pretransplantation mortality has been reported in the pediatric series. In those cases, the indication of IT shouldn't be delayed, and these children must be referred early for IT. Since we started our IT program, 17 children have been assessed, and 3 are currently on the waiting list; two for combined liver-small bowel transplantation (LSB), both with short bowel syndrome and end stage liver disease, and one patient with microuvillous dysplasia for isolated IT (indication loss of venous access). 3 children were referred too late and died, so did a fourth patient, candidate for LSB, before he could be transplanted.
Collapse
Affiliation(s)
- M López Santamaría
- S. de Gastroenterología, U. de Nutrición, S. de Hepatología, Dpto. de Cirugía, U. de Trasplantes Digestivos, Hospital Infantil La Paz, Paseo de la Castellana 261, 28046 Madrid
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
48
|
López Santamaría M, Gámez M, Murcia J, Díez-Pardo J, Vázquez J, Migliazza L, Clavijo J, Tovar J, Hierro L, Frauca E, Camarena C, de la Vega A, Díaz MC, Jara P. [Kasai operation in the age of liver transplantation. Healing or merely palliative technique?]. Cir Pediatr 2000; 13:102-5. [PMID: 12601938] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/01/2023]
Abstract
AIM To assess the results of portoenteroanastomosis (PEA) and liver transplantation (OLT) in extrahepatic biliary atresia (EHBA). METHODS Out of a series of 148 EHBA, 92 cases primarily treated by us were selected. Survival with the native liver (end point = death or OLT) and its relationship with the age at PEA, type of EHBA, ductal size and bile flow restablishment were assessed. Patient survival was compared in those patients who had access to OLT when needed (Group I, n = 69) and those in whom only PEA was available (Group II, n = 23). (OLT program started in january 1986). RESULTS At the end of follow-up, 32 children are alive with their native livers, 22 died and 38 had OLT. 40/85 patients who underwent PEA had complete restablishment of bile flow (47%). The no failure rate (survival of the native liver) at 1, 5, 10 and 20 years, was 91%, 49%, 38% and 21%, respectively. Bile flow restablishment was the only predictor significantly associated with good prognosis (survival of native liver at 5, 10 and 20 years of 89%, 86% and 51%, respectively). Differences in survival were significant (p < 0.001) between patients in groups I and II at 1 year (92% vs 74%), 5 years (78% vs 35%), 10 years (76% vs 30%) and 20 years (76% vs 30%). CONCLUSIONS Bile flow restablishment after PEA can be obtained in experienced centers in about 50% of cases of EHBA. The combined and sequential use of PEA and OLT allows excellent long-term survival in EHBA.
Collapse
Affiliation(s)
- M López Santamaría
- Dpto. de Cirugía, Unidad de Trasplantes, Serv. de Hepatología, Hospital Infantil La Paz, Paseo de la Castellana 261, 28046 Madrid
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Schafer S, Shore W, French L, Tovar J, Hughes S, Hearst N. Rejecting family practice: why medical students switch to other specialties. Fam Med 2000; 32:320-5. [PMID: 10820673] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/16/2023]
Abstract
BACKGROUND AND OBJECTIVES Medical schools have been encouraged to increase the number of primary care graduates. This study determined the proportion of medical students who change specialty preference during the clinical years and explored how ultimate choice is affected by perceptions of medical specialties acquired during this period. METHODS A survey was mailed to 397 graduating medical students at the University of California, San Francisco (UCSF) after the National Resident Matching Program Match and before graduation in 1996, 1997, and 1998. RESULTS The response rate was 81% (320/397). Of 41 respondents who reported that family practice had been their first specialty choice prior to beginning clinical rotations, only 15 (37%) eventually matched in family practice. Comparable numbers for internal medicine and pediatrics were 50% and 69%. Students rejecting family practice were more likely than their colleagues rejecting other specialties to cite insufficient prestige, low intellectual content, and concern about mastering too broad a content area as reasons. CONCLUSIONS At UCSF, family practice retains fewer interested students than other primary care specialties. To reverse this trend, schools such as UCSF need to raise the prestige of family practice and counter concerns about its intellectual content being impossible to master.
Collapse
Affiliation(s)
- S Schafer
- University of California, San Francisco (UCSF)-Fresno Family Practice Residency, USA.
| | | | | | | | | | | |
Collapse
|
50
|
López-Santamaria M, Migliazza L, Gamez M, Murcia J, Diaz-Gonzalez M, Camarena C, Hierro L, De la Vega A, Frauca E, Diaz M, Jara P, Tovar J. Liver transplantation in patients with homozygotic familial hypercholesterolemia previously treated by end-to-side portocaval shunt and ileal bypass. J Pediatr Surg 2000; 35:630-3. [PMID: 10770402 DOI: 10.1053/jpsu.2000.0350630] [Citation(s) in RCA: 48] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Familial hypercholesterolemia is the result of mutations in the gene that encodes the synthesis of the cellular receptor for low density lipoprotein (LDL). In the homozygous form of the disease (HFHC), cellular LDL receptors either do not form, or, when present, cannot bond LDL and mediate its cellular uptake LDL, and the cholesterol that it transports accumulate in plasma, producing severe premature atherosclerosis and death from coronary artery disease usually before the age of 20. Currently, the only effective treatment is liver transplantation, which, alone or in association with medications, normalizes plasma cholesterol levels. The authors report the cases of 2 siblings with HFHC who underwent portocaval shunt at the ages of 2.5 and 1.5 years, respectively. Portocaval shunt produced an immediate, but insufficient decrease in cholesterol (by 40% and 35%, respectively), leaving them with cholesterol concentrations of about 500 mg/dL. One year later they each underwent ileal bypass without obtaining any significant response. Liver transplantation at the ages of 18 and 16 years, respectively, reduced plasma cholesterol concentrations to 129 and 225 mg/dL, respectively. The earlier operations seriously increased the technical difficulty of liver transplantation and did not produce a favorable effect on the natural course of the disease, so portocaval shunt and ileal bypass are not indicated in HFHC, not even for the purpose of delaying liver transplantation.
Collapse
Affiliation(s)
- M López-Santamaria
- Department of Pediatric Surgery, Pediatric Hospital La Paz, Madrid, Spain
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|